ClinChoice Join Hands with Anju Software To Simplify the Complexities of Life Science Information Management

Anju Software, a top supplier of life science technologies, stated that TrialMaster and Anju's eClinical Suite will help ClinChoice grow its market share. Through the cooperation, ClinChoice is able to offer a complete line of flexible, affordable eClinical solutions that give valuable information and quick outcomes. "With our acquisition of Cromsource, we welcomed Anju as a partner for eClinical solutions," stated Tiepu Liu, Clinchoice President of Global Biometrics.

"The Cromsource team has over ten years of experience designing and managing Phase I-IV clinical trials on TrialMaster, one of the most intuitive, feature-rich electronic data capture solutions on the market." "We look forward to supporting ClinChoice as they increase their global presence," stated Michael Loftus, Anju Vice President of CRO Partner Program. "Our adaptable technologies paired with Anju's customer-first approach enables our partners to rapidly deliver solutions that scale."

In order to hasten the development and approval to market of life-saving pharmaceuticals and equipment, organisations performing clinical research can use TrialMaster to streamline the collecting, processing, and submission of clinical trial data to regulatory bodies.

TrialMaster integrates ePRO, autoencoding, SAE reporting, and eConsent into a single system and covers Phase I through IV multilingual clinical trials. It is also available from any electronic device. A global clinical CRO, ClinChoice is committed to providing biopharmaceutical, vaccine, medical device, and consumer product firms with top-notch services. Clinical Operations, Project Management, Biostatistics and Programming, Data Management, Regulatory Affairs and Medical Affairs, Pharmacovigilance, Cosmetovigilance, Toxicology, as well as Medical Writing and other product development services, are some of the services offered. With more than 4,000 committed specialists, ClinChoice has delivery centres all across the US, Canada, Europe, India, the Philippines, Japan, and China.